Earnings Call · Q1 FY2024·2024-05-08

Q1 24EPS +16.67%·Rev n/aQ4 23EPS -48.15%·Rev n/aQ3 23EPS -33.33%·Rev n/aQ2 23EPS +55.88%·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Nichol Ochsner — Unknown

Neil Mcfarlane — Unknown

LaDuane Clifton — Unknown

−0.3%1d on move date−0.3% vs SPY3d−6.9%5d−7.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access